Pharma Pulse: TrumpRx Gains Nine New Pharma Partners; DHL Expands LAX Cold Chain Hub

Welcome to Pharma Pulse, a Pharmaceutical Commerce podcast where we bring you the latest insights shaping patient access, supply chain/logistics, data & tech, and healthcare innovation. I’m your host, and let’s get into today’s headlines.

• First, President Trump has announced nine additional participants for the TrumpRx program, including industry heavyweights like Merck, Novartis, GSK, and Amgen. This brings the total to 14 of the 17 targeted companies now reaching agreements to offer “most-favored-nation” pricing. During the announcement, the president credited his use of tariffs as leverage to align US drug costs with the lower prices found in Europe. The government-run TrumpRx website is scheduled to launch in 2026, aiming to offer deep discounts directly to consumers.
• In logistics news, DHL Global Forwarding is expanding its cold storage footprint at LAX with a new $1.5 million investment. As part of a broader $2.3 billion global health logistics strategy, the facility will enhance the safe handling of temperature-sensitive pharmaceuticals. Featuring advanced real-time monitoring, the site serves as a vital gateway for high-value trade between the Americas and Asia-Pacific.

That’s it for this episode of Pharma Pulse. For more insights on trends transforming pharmaceutical access and care delivery, visit pharmaceuticalcommerce.com.

Thanks for listening—until next time, stay well and stay informed.

You can catch Pharma Pulse directly on Audioboom, Spotify, or iHeart.